Stephen Cartt MBA '91 : Appointed President & CEO of Asterias Biotherapeutics
Business School alumnus Stephen Cartt MBA ‘91 was recently appointed President, CEO, and member of the Board of Directors of Asterias Biotherapeutics.
"I look forward to working with the Asterias team and the Board to further the company's clinical development of important treatments,” said Cartt in a recent press release. “We believe that over time, these efforts have the potential to build significant returns for our shareholders."
Find the full press release here.
Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine.
Mar 1, 2016